Dragon Pharma DSIP 10 MG

IDENTITYCompoundDelta Sleep-Inducing Peptide (DSIP)
BrandDragon Pharma
Strength10 mg
FormLyophilized Powder
ClassPeptide Research Compound

PEPTIDE PROFILEStructureNonapeptide
Amino Acids9 Amino Acid Sequence
AdministrationSubcutaneous Injection (SC)
Primary AreaSleep Regulation Research
Clinical StatusInvestigational

PHARMACOLOGYCategoryNeuropeptide
Main FunctionSleep-Wake Modulation
Target SystemCentral Nervous System
Research FocusRecovery & Sleep Quality
MetabolismPeptide Degradation Pathways

STORAGE & PACKAGEBrandDragon Pharma
Package2 ml Vial x 10 mg
FormLyophilized Powder
Storage2-8°C Refrigerated
Protect FromLight & Heat

ADMINISTRATION PROFILEUsageResearch Sleep Support
RouteSubcutaneous Injection
TimingUsually Evening / Before Sleep
FrequencyDaily Research Protocols
DurationSeveral Weeks

DOSING INFORMATIONResearch Dose100-300 mcg/day
AdministrationSubcutaneous Injection
Timing30-60 Minutes Before Sleep
Duration4-8 Weeks Research Period
UsageSleep & Recovery Research

RECOVERY PROFILESleep QualityResearch Interest
RecoveryIndirect Support
Stress ResponseNeuroendocrine Research
Training ImpactRecovery Dependent
Bodybuilding UseSleep Optimization Research

COMPATIBILITYSleep StackSleep Hygiene Protocols
Recovery StackTraining Recovery Research
NutritionHigh Protein Diet Support
TrainingResistance Exercise Programs
CombinationResearch Dependent

MECHANISM OF ACTIONTargetCentral Nervous System
ActionNeuropeptide Signaling
SleepModulation Research
HormonesNeuroendocrine Interaction
RecoveryIndirect Physiological Effects

PHARMACOKINETICSAbsorptionPeptide Injection Pathway
DistributionSystemic Peptide Exposure
Half-LifeLimited Human Data
ClearanceEnzymatic Peptide Breakdown
ResearchOngoing Investigation

SAFETY PROFILEClinical ApprovalNot Approved Drug Therapy
Injection RiskPossible Local Reaction
DataLimited Human Evidence
MonitoringRecommended In Research
Long TermInsufficient Data

CHEMICAL PROFILECompoundDelta Sleep-Inducing Peptide
ClassNeuropeptide
FormulaNot Consistently Reported
Molecular WeightApproximately 848 Da
SequenceTrp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

OVERVIEW

Dragon Pharma DSIP 10 MG contains Delta Sleep-Inducing Peptide, a synthetic nonapeptide investigated for its possible involvement in sleep regulation, neuroendocrine signaling and recovery-related processes. In bodybuilding communities, DSIP is mainly discussed as a research compound related to sleep quality, recovery capacity and training adaptation through improved rest.

BENEFITS

Research interest in sleep regulation
Potential recovery support through sleep improvement
Neuropeptide activity investigation
May influence relaxation pathways
Used in sleep-related research protocols
Supports interest in recovery optimization

POTENTIAL RISKS

Limited clinical human data
Possible injection site reactions
Unknown long-term effects
Individual response variation
Not approved as prescription therapy
Insufficient bodybuilding-specific evidence

PERFORMANCE PROFILE

Recovery

75%

Sleep Quality

80%

Stress Support

60%

Lean Mass

30%

Direct Performance

25%

CONCLUSION

Dragon Pharma DSIP 10 MG is a lyophilized peptide preparation containing Delta Sleep-Inducing Peptide, a compound investigated for possible effects on sleep regulation and neuroendocrine processes.

Unlike anabolic steroids or growth hormone-related compounds, DSIP does not directly function as an anabolic agent. Its bodybuilding relevance is primarily connected with recovery research, sleep quality and the role of restorative sleep in athletic performance.

Scientific evidence remains limited, and DSIP should be considered an investigational peptide rather than an established performance-enhancing medication.

Disclaimer

This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, treatment recommendations or endorsement of non-approved research compound use. Always consider qualified medical guidance and applicable regulations.